Equities

Dr Miele Cosmed Group SA

Dr Miele Cosmed Group SA

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (PLN)5.10
  • Today's Change-0.14 / -2.67%
  • Shares traded18.48k
  • 1 Year change+47.40%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of PLN
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments149.3911
Total Receivables, Net514445
Total Inventory515442
Prepaid expenses0.800.010.20
Other current assets, total4.436.966.56
Total current assets121114105
Property, plant & equipment, net133136133
Goodwill, net303030
Intangibles, net949494
Long term investments4.740.070.07
Note receivable - long term------
Other long term assets------
Total assets382374362
LIABILITIES
Accounts payable606761
Accrued expenses121110
Notes payable/short-term debt363525
Current portion long-term debt/capital leases6.762110
Other current liabilities, total3.723.905.62
Total current liabilities118139112
Total long term debt171120
Total debt606755
Deferred income tax111111
Minority interest------
Other liabilities, total1.941.541.73
Total liabilities148162144
SHAREHOLDERS EQUITY
Common stock878787
Additional paid-in capital------
Retained earnings (accumulated deficit)149127132
Treasury stock - common(1.15)(1.15)(1.12)
Unrealized gain (loss)------
Other equity, total(1.03)(0.71)(0.72)
Total equity234213217
Total liabilities & shareholders' equity382374362
Total common shares outstanding878787
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.